EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells
EZH2 抑制通过降低 CD8+ T 细胞的存活率和效应子编程而损害 α4-1BB 介导的抗肿瘤功效
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2021.770080
Christopher J Stairiker, Sophia Xiao Pfister, Eleanore Hendrickson, Wenjing Yang, Tao Xie, Catherine Lee, Haikuo Zhang, Christopher Dillon, Graham D Thomas, Shahram Salek-Ardakani
